Associations
newsletter
subscribe
advertise
contact
Technology
pulseTV
Buyer's Guide
Comparison Charts
Blogs
Events
Webinars
Magazine
Cardiac Diagnostics
ECG
ECG Management Systems
Holter Monitoring Systems
Stress Test Systems
Cardiac Imaging
Advanced Visualization
Angiography Systems
Cardiovascular Ultrasound
Contrast Media
CT Systems
Hybrid OR
MRI Systems
Nuclear Imaging
Cath Lab
Angiography Systems
Balloon Catheters
Hemostasis Management
Intravascular Imaging Systems
Interventional Radiology
Hybrid OR
Radial Access
Stents
Ventricular Assist Devices (VAD)
EP Lab
Ablation Systems
Cardiac Resynchronization Therapy Devices (CRT)
Implantable Cardioverter Defibrillators (ICD)
Leads, implantable devices
Pacemakers
Information Technology
Advanced Visualization
Cardiac PACS
Telecardiology
Structural Heart
Heart Valve Repair
Hybrid OR
Left Atrial Appendage (LAA) Occluders
Structural Heart Occluders/Closure Devices
Biosensors International Group Ltd.
Related Articles
Stents, Bare Metal
Interventional Cardiology Devices Forecast
Stents
Interventional Cardiology Devices Forecast
Axxess Self-Expanding Bifurcation DES Shown to be Safe and Effective Up to Four Years
AXXESS PLUS Trial Shows Long-Term Safety, Efficacy of Biosensors DES
Biosensors Acquires Top Chinese Stent Maker
New Directions for Stent Technology
Stents, Bioresorbable
Interventional Cardiology Devices Forecast
Biodegradable Polymer DES Reduce Stent Thrombosis Rates
New Directions for Stent Technology
Stents, Drug Eluting
Interventional Cardiology Devices Forecast
Biosensors Receives CE Mark Approval for BioFreedom
Biosensors Announces First Patient Enrolled in LEADERS FREE
Biosensors Announces First Large-Scale Study with BioFreedom
Axxess Self-Expanding Bifurcation DES Shown to be Safe and Effective Up to Four Years
Biodegradable Polymer DES Reduce Stent Thrombosis Rates
BioFreedom Trial Demonstrates Comparable Long-Term Safety, Efficacy to Conventional DES
AXXESS PLUS Trial Shows Long-Term Safety, Efficacy of Biosensors DES
Biosensors Acquires Top Chinese Stent Maker
Axxess Self-Expanding Bifurcation Drug-Eluting Stent Safe, Effective at Three Years
New Data Confirms Safety of BioMatrix at One Year
Cardiologists Implant DES in Three Patients Live from JIM
BioFreedom
Cath Lab
Interventional Cardiology Devices Forecast
Biosensors Receives CE Mark Approval for BioFreedom
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
Biodegradable Polymer DES Reduce Stent Thrombosis Rates
Clinical Trial/Study
Biosensors Announces First Patient Enrolled in LEADERS FREE
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
Biosensors Announces First Large-Scale Study with BioFreedom
Axxess Self-Expanding Bifurcation DES Shown to be Safe and Effective Up to Four Years
Biodegradable Polymer DES Reduce Stent Thrombosis Rates
BioFreedom Trial Demonstrates Comparable Long-Term Safety, Efficacy to Conventional DES
Axxess Self-Expanding Bifurcation Drug-Eluting Stent Safe, Effective at Three Years
New Data Confirms Safety of BioMatrix at One Year
Pharmaceuticals
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
Antiplatelet Therapy
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
